BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36112085)

  • 1. Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9).
    Basuroy T; Dreier M; Baum C; Blomquist T; Trumbly R; Filipp FV; de la Serna IL
    Pigment Cell Melanoma Res; 2023 Jan; 36(1):19-32. PubMed ID: 36112085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAF60A mediates interactions between the microphthalmia-associated transcription factor and the BRG1-containing SWI/SNF complex during melanocyte differentiation.
    Aras S; Saladi SV; Basuroy T; Marathe HG; Lorès P; de la Serna IL
    J Cell Physiol; 2019 Jul; 234(7):11780-11791. PubMed ID: 30515787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation.
    Trivedi A; Mehrotra A; Baum CE; Lewis B; Basuroy T; Blomquist T; Trumbly R; Filipp FV; Setaluri V; de la Serna IL
    Epigenetics Chromatin; 2020 Mar; 13(1):14. PubMed ID: 32151278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRG1 interacts with SOX10 to establish the melanocyte lineage and to promote differentiation.
    Marathe HG; Watkins-Chow DE; Weider M; Hoffmann A; Mehta G; Trivedi A; Aras S; Basuroy T; Mehrotra A; Bennett DC; Wegner M; Pavan WJ; de la Serna IL
    Nucleic Acids Res; 2017 Jun; 45(11):6442-6458. PubMed ID: 28431046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdx2 Regulates Gene Expression through Recruitment of Brg1-associated Switch-Sucrose Non-fermentable (SWI-SNF) Chromatin Remodeling Activity.
    Nguyen TT; Savory JGA; Brooke-Bisschop T; Ringuette R; Foley T; Hess BL; Mulatz KJ; Trinkle-Mulcahy L; Lohnes D
    J Biol Chem; 2017 Feb; 292(8):3389-3399. PubMed ID: 28082674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors.
    Krämer KF; Moreno N; Frühwald MC; Kerl K
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28714904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding specificity and function of the SWI/SNF subunit SMARCA4 bromodomain interaction with acetylated histone H3K14.
    Enríquez P; Krajewski K; Strahl BD; Rothbart SB; Dowen RH; Rose RB
    J Biol Chem; 2021 Oct; 297(4):101145. PubMed ID: 34473995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microphthalmia-associated transcription factor requires SWI/SNF enzymes to activate melanocyte-specific genes.
    de la Serna IL; Ohkawa Y; Higashi C; Dutta C; Osias J; Kommajosyula N; Tachibana T; Imbalzano AN
    J Biol Chem; 2006 Jul; 281(29):20233-41. PubMed ID: 16648630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation.
    Sharma T; Robinson DCL; Witwicka H; Dilworth FJ; Imbalzano AN
    Nucleic Acids Res; 2021 Aug; 49(14):8060-8077. PubMed ID: 34289068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibition.
    Ali MM; Naz S; Ashraf S; Knapp S; Ul-Haq Z
    Int J Biol Macromol; 2023 Mar; 230():123428. PubMed ID: 36709803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors.
    Wang X; Wang S; Troisi EC; Howard TP; Haswell JR; Wolf BK; Hawk WH; Ramos P; Oberlick EM; Tzvetkov EP; Ross A; Vazquez F; Hahn WC; Park PJ; Roberts CWM
    Nat Commun; 2019 Apr; 10(1):1881. PubMed ID: 31015438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SWI/SNF chromatin remodeling enzymes in melanocyte differentiation and melanoma.
    Mehrotra A; Mehta G; Aras S; Trivedi A; de la Serna IL
    Crit Rev Eukaryot Gene Expr; 2014; 24(2):151-61. PubMed ID: 24940768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
    Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
    Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expression.
    Marathe HG; Mehta G; Zhang X; Datar I; Mehrotra A; Yeung KC; de la Serna IL
    PLoS One; 2013; 8(7):e69037. PubMed ID: 23874858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress of selective small molecule bromodomain-containing protein 9 inhibitors.
    Hui M; Jian Z; Peiyuan Z; Zhenwei W; Huibin Z
    Future Med Chem; 2018 Apr; 10(8):895-906. PubMed ID: 29620420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
    Vachtenheim J; Ondrusová L; Borovanský J
    Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.
    Wilson BG; Helming KC; Wang X; Kim Y; Vazquez F; Jagani Z; Hahn WC; Roberts CW
    Mol Cell Biol; 2014 Mar; 34(6):1136-44. PubMed ID: 24421395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.
    Laurette P; Coassolo S; Davidson G; Michel I; Gambi G; Yao W; Sohier P; Li M; Mengus G; Larue L; Davidson I
    Cell Death Differ; 2020 Jan; 27(1):29-43. PubMed ID: 31065107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Brahma expression by the mitogen-activated protein kinase/extracellular signal regulated kinase pathway is associated with changes in melanoma proliferation.
    Mehrotra A; Saladi SV; Trivedi AR; Aras S; Qi H; Jayanthy A; Setaluri V; de la Serna IL
    Arch Biochem Biophys; 2014 Dec; 563():125-35. PubMed ID: 25026375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
    Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
    Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.